Latest News and Press Releases

Noted pharmaceutical industry executive Frederick Beddingfield, MD, PhD, has joined the Neurodon Board of Directors, bringing years of industry leadership.

BENGALURU, India, June 10, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery...

BENGALURU, India, June 09, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery...

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Session

June 4, 2025 Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical...

Dublin, May 26, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Care Market in India (2025-2030" report has been added to ResearchAndMarkets.com's offering.The diabetes care market in India was valued at...

DALLAS, May 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging...

UMeWorld Achieves Major Milestone with U.S. Pilot Bottling of DAGola Functional Oils; Announces New High-Performance Chef Blend

Aeroflow’s Comprehensive Diabetes Management Program is built to streamline the diabetes management process for both patients and providers.

The U.S. Phase 2 trial aims to evaluate efficacy and safety of CX11 in doses up to 200 mg and different titration schemesThe trial is expected to enroll 250 patients to receive treatment over 36 weeks...